Literature DB >> 11668643

Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.

S Salvi1, C Dionisi-Vici, E Bertini, M Verardo, F M Santorelli.   

Abstract

Eight unrelated Italian patients with the hyperornithinemia, hyperammonemia, and homocitrullinuria (HHH) syndrome were analyzed for mutations in the ORNT1 gene. Seven novel mutations were identified (Q89X, G27R, G190D, R275Q, c.861insG, c.164insA, and IVS5+1G-->A). Other previously described variants were a heterozygous deletion of a phenylalanine residue (F188del) in one allele and the R179X in two. The G27R mutation was carried by two patients. Analyses of ORNT1 mRNA in four patients showed that mutant alleles were stable and of the predicted size. The current study expands the spectrum of mutations in ORNT1 gene. Copyright Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668643     DOI: 10.1002/humu.1221

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Substrate specificity of the two mitochondrial ornithine carriers can be swapped by single mutation in substrate binding site.

Authors:  Magnus Monné; Daniela Valeria Miniero; Lucia Daddabbo; Alan J Robinson; Edmund R S Kunji; Ferdinando Palmieri
Journal:  J Biol Chem       Date:  2012-01-19       Impact factor: 5.157

2.  Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.

Authors:  AbdulRazaq A H Sokoro; Joyce Lepage; Nick Antonishyn; Ryan McDonald; Cheryl Rockman-Greenberg; James Irvine; Denis C Lehotay
Journal:  J Inherit Metab Dis       Date:  2010-06-24       Impact factor: 4.982

3.  Mitochondrial carriers in the cytoplasmic state have a common substrate binding site.

Authors:  Alan J Robinson; Edmund R S Kunji
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-09       Impact factor: 11.205

4.  Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 5.  The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Diego Martinelli; Daria Diodato; Emanuela Ponzi; Magnus Monné; Sara Boenzi; Enrico Bertini; Giuseppe Fiermonte; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2015-03-11       Impact factor: 4.123

6.  Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma.

Authors:  Seong-Hwi Hong; Kwang-Suk Lee; Hyun-Ji Hwang; Sung-Yul Park; Woong-Kyu Han; Young-Eun Yoon
Journal:  Genes (Basel)       Date:  2022-07-06       Impact factor: 4.141

7.  Role of early management of hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome in pregnancy.

Authors:  Matthew James Billingham; Rania Rizk
Journal:  BMJ Case Rep       Date:  2021-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.